Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean iothalamate sodium i 1,5?
Displaying drugs 3451 - 3475 of 4240 in total

PIK3CA

PIK3CA is under investigation in clinical trial NCT02957266 (Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy).
Investigational

4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole

Experimental

N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine

Experimental

Gimatecan

Gimatecan is an orally available 7-t-butoxyiminomethyl-substituted lipophilic camptothecin derivative.
Investigational

Porphobilinogen deaminase, human recombinant

Investigational

Vudalimab

Vudalimab is under investigation in clinical trial NCT05005728 (Xmab®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-resistant Prostate Cancer).
Investigational

N-(4-(1-cyclopropyl-4-fluoro-2-methyl-1H-benzo(d)imidazol-6-yl)-5-fluoropyrimidin-2-yl)-6-(2-(dimethylamino)ethyl)-5,6,7,8-tetrahydro-l,6-naphthyridin-2-amine

Investigational

Crovalimab

Crovalimab is under investigation in clinical trial NCT03157635 (Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria).
Investigational

ATM-3507

Investigational

Linafexor

Investigational

CP-12

Investigational

Gresonitamab

Investigational

Vepsitamab

Investigational

4-Iodobenzo[B]Thiophene-2-Carboxamidine

Experimental

4-[(Isopropylamino)Methyl]Phenylalanine

Experimental

BB-1701

BB-1701 is a humanized IgG1 kappa monoclonal antibody (anti-HER2 antibody) conjugated to eribulin developed by Bliss Biopharmaceutical.
Investigational

RGG0853

RGG0853 is an E1A lipid complex, a repressor gene complexed with a cationic lipid vector.
Investigational

Bexicaserin

Bexicaserin is under investigation in clinical trial NCT05626634 (Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy).
Investigational

Begelomab

Begelomab is a murine monoclonal antibody against CD26.
Experimental
Investigational

Palazestrant

Palazestrant is under investigation in clinical trial NCT06016738 (OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer).
Investigational

Pomotrelvir

Pomotrelvir is under investigation in clinical trial NCT05543707 (PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19).
Investigational

Nerinetide

Na 1 is under investigation in clinical trial NCT00728182 (Evaluating Neuroprotection in Aneurysm Coiling Therapy).
Investigational

Sabatolimab

Sabatolimab is under investigation in clinical trial NCT03946670 (A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS).).
Investigational

Azercabtagene zapreleucel

Investigational

6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid

Experimental
Displaying drugs 3451 - 3475 of 4240 in total